Copyright
©The Author(s) 2018.
World J Gastroenterol. Sep 7, 2018; 24(33): 3770-3775
Published online Sep 7, 2018. doi: 10.3748/wjg.v24.i33.3770
Published online Sep 7, 2018. doi: 10.3748/wjg.v24.i33.3770
Table 2 Comparison of metrics of physical frailty by beta-blocker use
Outcome | On beta blockers | Not on beta blockers | P value |
n = 181 (53%) | n = 163 (47%) | ||
Liver frailty index1 | 3.75 (3.37-4.15) | 3.64 (3.23-4.04) | 0.04 |
Chair stands (s) | 12.5 (10-16.2) | 10.9 (8.3-13.2) | 0.003 |
Grip strength (kg) | 33.3 (24.3-40) | 29 (22-37) | 0.03 |
Balance (s) | 30 (30-30) | 30 (26.6-30) | 0.20 |
LFI Frail | 14% | 14% | 0.98 |
LFI Robust | 16% | 25% | 0.06 |
Exhaustion | 51% | 52% | 0.89 |
MNLTPA frailty | 58% | 60% | 0.69 |
- Citation: Kuo SZ, Lizaola B, Hayssen H, Lai JC. Beta-blockers and physical frailty in patients with end-stage liver disease. World J Gastroenterol 2018; 24(33): 3770-3775
- URL: https://www.wjgnet.com/1007-9327/full/v24/i33/3770.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i33.3770